Matrix-assisted laser desorption ionization-time of flight mass spectrometry can be used to identify Helicobacter cinaedi.


Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 10 08 2019
revised: 25 11 2019
accepted: 06 12 2019
pubmed: 31 12 2019
medline: 2 10 2020
entrez: 30 12 2019
Statut: ppublish

Résumé

We examined the applicability of Matrix-assisted laser desorption ionization-time of flight mass spectrometry using 54 Helicobacter cinaedi isolates from humans. In all 54 isolates, MALDI-TOF MS detected H. cinaedi as the best match organism. Our findings suggest that MALDI TOF-MS can be used effectively to identify H. cinaedi.

Identifiants

pubmed: 31884027
pii: S0732-8893(19)30808-9
doi: 10.1016/j.diagmicrobio.2019.114964
pii:
doi:

Substances chimiques

DNA, Bacterial 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114964

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Yusuke Endo (Y)

Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.

Hideki Araoka (H)

Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan; Department of Infection Control and Prevention, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Electronic address: h-araoka@toranomon.gr.jp.

Masaru Baba (M)

Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.

Chikako Okada (C)

Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.

Muneyoshi Kimura (M)

Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.

Yoshimi Higurashi (Y)

Department of Infection Control and Prevention, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Tomoaki Sato (T)

Department of Infection Control and Prevention, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Yutaka Yatomi (Y)

Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Kyoji Moriya (K)

Department of Infection Control and Prevention, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Electronic address: moriya-tky@umin.ac.jp.

Akiko Yoneyama (A)

Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH